Microbiome and Endometrial Receptivity in Obese Infertile Women

Endometrial Receptivity Clinical Trial

Official title:

Microbiome and Endometrial Receptivity in Obese Infertile Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03493529
• Other study ID #: 1711-VLC-108-JB
• Status: Completed
• Start date: May 31, 2018
• Est. completion date: December 31, 2022

Study information

• Verified date: October 2023
• Source: Instituto Valenciano de Infertilidad, IVI VALENCIA
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The objective of this project is the identification and quantification of the main bacterial communities present in the endometrial microbiota in obese infertile patients, to assess if there is an alteration of their composition dependent on the body mass index, and if such alteration it could influence the reduction of endometrial receptivity, demonstrated in obese women. If obese patients have an altered digestive microbiota and, at the same time, a lower endometrial receptivity, the investigator want to assess whether such reduction in receptivity may depend on an alteration in the endometrial microbiota, which in non-obese infertile patients has been shown to negatively influence the reproductive results

Description:

The main objective of our study is to compare the composition of the endometrial microbiota between patients with normal weight and patients with obesity.

A. Secondary Objectives/research questions

• To analyze the composition of the digestive microbiota through samples of saliva and feces in infertile patients with normal weight and obesity.

• To assess whether there is a relationship between the body mass index (normal weight, obesity Class I, Class II, Class III) and the main bacterial species detected in endometrial fluid samples from infertile patients.

• To evaluate the influence of the digestive microbiota on the composition of the endometrial microbiota according to the body mass index in infertile patients.

• To evaluate if there is an influence of the endometrial microbiota on the results of endometrial receptivity analyzed with the non-invasive Endometrial Receptivity Array test (niERA)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: December 31, 2022
• Est. primary completion date: September 16, 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 44 Years

Eligibility

Inclusion Criteria:

• Infertile patients undergoing artificial cycle with HRT.

• Normal uterus confirmed by ultrasound (absence of uterine pathology such as submucosal or intramural myomas> 4 cm that deform cavity, endometrial polyps or Müllerian anomalies, or adnexal as communicating hydrosalpinx).

• Negative serological tests for HIV, HBV, HCV, RPR

Exclusion Criteria:

• Taking prescribed antibiotics or using IUDs or contraceptives 3 months prior to taking the sample. NOTE: Patients who have taken prophylactic antibiotics for ovarian puncture may be included at least 1 month before taking the sample.

• Age> 45 years

• Uncorrected uterine pathology, uncorrected hydrosalpinx

• Recurrent miscarriage (=2 spontaneous abortions) or failure of implantation (transfer of 6 embryos in day 3 or 4 blastocysts in a cycle of IVF or donation of oocytes without gestation)

• Existence of serious or uncontrolled bacterial, fungal or viral infections that, in the opinion of the principal investigator, could interfere with the participation of the patient in the study or in the evaluation of the results of the study.

• Any disease or medical condition that is unstable or could endanger the patient's safety and compliance in the study.

Related Conditions & MeSH terms

• Endometrial Receptivity
• Infertility

Locations

Country	Name	City	State
Spain	Ivi Valencia	Valencia

Sponsors (4)

Lead Sponsor	Collaborator
Instituto Valenciano de Infertilidad, IVI VALENCIA	Igenomix, IVI Barcelona, IVI Bilbao

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Microbiological analysis of endometrial fluid samples through massive sequencing	Identification and quantification of the main bacterial communities present in the endometrial microbiota of obese and normal-weight infertile patients through the analysis of the endometrial fluid.	14 months
Secondary	Microbiological analysis of saliva samples through massive sequencing.	Identification and quantification of the main bacterial communities present in the oral microbiota of obese and normal-weight infertile patients through the analysis of saliva samples.	14 months
Secondary	Microbiological analysis of feces samples through massive sequencing.	Identification and quantification of the main bacterial communities present in the intestinal microbiota of obese and normal-weight infertile patients through the analysis of feces samples.	14 months
Secondary	Analysis of endometrial receptivity using niERA	Analysis of the optimal implantation window through the study of the expression of 238 genes involved in receptivity using endometrial fluid samples.	13 months